BioCentury
ARTICLE | Company News

OctoPlus, Dr. Reddy's deal

March 11, 2013 7:00 AM UTC

The companies said that as of Feb. 26, Dr. Reddy holds 98.6%, or about 51.9 million shares, of OctoPlus. The companies are requesting NYSE Euronext Amsterdam to terminate OctoPlus' listing and trading...